Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Reduction of Vascular Inflammation and Coronary Atherosclerosis With AGI-1067, a V-Protectant, Reduces Cardiovascular Events in Patients With Coronary Artery Disease"

NCT00066898 is registered in ClinicalTrials.gov with AtheroGenics as lead sponsor.

NCT NCT00066898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00066898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Reduction of Vascular Inflammation and Coronary Atherosclerosis With AGI-1067, a V-Protectant, Reduces Cardiovascular Events in Patients With Coronary Artery Disease"
Lead sponsor
AtheroGenics
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2003
Completion date
December 31, 2006
Enrollment
6,000
Sites
219

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, coronary artery disease, myocardial infarction, unstable angina